The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate.

Garassino, M C; Vyas, M; de Vries, E G E; Kanesvaran, R; Giuliani, R; Peters, S

Garassino, M C; Vyas, M; de Vries, E G E; Kanesvaran, R; Giuliani, R; Peters, S.

Garassino MC; Thoracic Oncology, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: Marina.Garassino@istitutotumori.mi.it.
Vyas M; European Society for Medical Oncology, Lugano, Switzerland.
de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
Giuliani R; The Clatterbridge Cancer Centre, Liverpool, UK.
Peters S; Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Ann Oncol ; 32(5): 579-581, 2021 05.

Article in English | MEDLINE | ID: covidwho-1081674

Subject(s)

COVID-19; Neoplasms; COVID-19 Vaccines; Humans; Neoplasms/therapy; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google